FindTrial
Sign In

Efficacy of GLP-1RAs on Glycemic Control evaluated by Continuous Glucose Monitoring in Patients with Type 2 Diabetes: a real-world study

Efficacy of GLP-1RAs on Glycemic Control evaluated by Continuous Glucose Monitoring in Patients with Type 2 Diabetes: a real-world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073697
Enrollment
Unknown
Registered
2023-07-19
Start date
2023-07-20
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T2DM

Interventions

GLP-1RAs group:NA
oral antihyperglycemic drug (OAD) group:NA

Sponsors

The First Affiliated Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.=18 years old; 2.Type 2 diabetes mellitus; 3.Patients with previous use of CGM system; 4. Treatment with GLP-1 receptor agonists or oral hypoglycemic agents for at least 3 months.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
TIR;HbA1c;—

Secondary

MeasureTime frame
TAR;TBR;mean glucose;—

Countries

China

Contacts

Public ContactYongru Chen

The First Affiliated Hospital of Shantou University Medical College

yongruchen@126.com+86 134 1196 9797

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026